Vidhya Kumaresan is a Research Assistant Professor in the Department of Pharmacology, Physiology, and Biophysics at the Boston University Chobanian and Avedisian School of Medicine. She obtained her MS and Ph.D. degrees from the University of Rhode Island, USA, and obtained postdoctoral training at Brown University, Rhode Island, USA, with an Individual NRSA Fellowship from the NIH and a Fellowship from the American Heart Association. Her research goal is to understand the molecular and cellular basis of neural plasticity and signaling mechanisms underlying neuropsychiatric disorders, particularly substance use disorders (SUDS). She uses rodent models and in vitro methods to investigate posttranslational modifications of receptors, receptor trafficking, and epigenetic mechanisms involved in the regulation of plasticity as a means of identifying novel therapeutic targets in SUDS. She has memberships in the Society for Neuroscience (SFN), the American Society for Pharmacology and Experimental Therapeutics (ASPET), and the International Behavioural and Neural Genetics Society (IBANGS).
Vidhya Kumaresan is a Research Assistant Professor in the Department of Pharmacology, Physiology, and Biophysics at the Boston University Chobanian and Avedisian School of Medicine. She obtained her MS and Ph.D. degrees from the University of Rhode Island, USA, and obtained postdoctoral training at Brown University, Rhode Island, USA, with an Individual NRSA Fellowship from the NIH and a Fellowship from the American Heart Association. Her research goal is to understand the molecular and cellular basis of neural plasticity and signaling mechanisms underlying neuropsychiatric disorders, particularly substance use disorders (SUDS). She uses rodent models and in vitro methods to investigate posttranslational modifications of receptors, receptor trafficking, and epigenetic mechanisms involved in the regulation of plasticity as a means of identifying novel therapeutic targets in SUDS. She has memberships in the Society for Neuroscience (SFN), the American Society for Pharmacology and Experimental Therapeutics (ASPET), and the International Behavioural and Neural Genetics Society (IBANGS).